PRIORITY share price & results
- Jun 2026
- Sept 2026
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 147 | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. No quarter a year earlier is in the series, so no change is shown. | |
| Operating margin | 7.0 | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. No quarter a year earlier is in the series, so no change is shown. | |
| Net profit | 6.5 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. No quarter a year earlier is in the series, so no change is shown. | |
| Return on equity | Trailing twelve months | TTM · period unavailable | Not in the analysed materials. No older figure is substituted. | ||
| Free cash flow margin | 2.71 | +2.9 pts | Fiscal year | FY ending Mar 2026 | (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue. |
| Revenue growth (YoY) | Trailing twelve months | TTM · period unavailable | Not in the analysed materials. No older figure is substituted. |
Price
Performance +47.1% YTD
YTD: ₹241.5 on 4 Sept 2026 → ₹355.35. High ₹359.8 (13 Oct 2026), low ₹218.53 (8 Sept 2026).
- Previous close
- ₹341.45
- Market cap
- ₹586 Cr
- 52-week range
- ₹218.53 – ₹359.8
- Price to earnings (FY ending Mar 2026)
- 32.56×
- Return on equity (FY ending Mar 2026)
- 13.04%
Overview
- Symbol
- NSE:PRIORITY
- Sector
- Consumer Durables
- Industry
- Consumer Discretionary
- Exchange
- NSE
- Currency
- INR
Fundamentals
Ratios, each with its period
Current values with the period they cover; the trend reads across the 2 fiscal years held (Mar 2025 to Mar 2026).
Financials
What the filings say
| Line item | Jun 2026 |
|---|---|
| Sales | 147 |
| Expenses | 136 |
| Operating profit | 10 |
| Operating margin | 7.0% |
| Other income | 1 |
| Interest | 2 |
| Depreciation | 1 |
| Profit before tax | 9 |
| Tax rate | 24.1% |
| Net profit | 6 |
| EPS (₹ per share) | 4.83 |
| Line item | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | — | 13 |
| Reserves | — | 125 |
| Borrowings | — | 104 |
| Other liabilities | — | 49 |
| Total liabilities | — | 292 |
| Fixed assets | — | 17 |
| Capital work in progress | — | 2 |
| Investments | — | 0 |
| Other assets | — | 273 |
| Total assets | — | 292 |
| Line item | Mar 2025 | Mar 2026 |
|---|---|---|
| Debtor days | — | 90 |
| Inventory days | — | 97 |
| Days payable | — | 35 |
| Cash conversion cycle | — | 152 |
| Working capital days | — | 86 |
| Dividend payout | 0.0% | 0.0% |
Ownership
Who owns it
Promoters hold 70.00% as of Sept 2026.
- Promoters 70.00%
- Foreign institutions 0.81%
- Domestic institutions 12.73%
- Public 16.46%
Who is on the register
Named in the Sep 2026 filing
Every holder of PRIORITY above SEBI's 1% disclosure line.
| Holder | Stake |
|---|---|
| Shailesh Sangani | 25.56% |
| Manisha Shailesh Sangani | 11.11% |
| Aditi Karan Motla | 11.11% |
| Aashna Sangani Parikh . | 11.11% |
| Priority Retail Ventures Private Limited | 10.76% |
| Sanshi Fund-I AIF | 2.40% |
| Whiteoak Capital Equity Fund | 2.40% |
| Plutus Investment Trust-Plutus Equity In | 1.69% |
| Khandelwal Finance Private Limited | 1.41% |
| Tushar Anantrai Mehta | 0.35% |
| Avalon Pharma Private Limited | 0.00% |
| Galentic Pharma (India) Private Limited | 0.00% |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Your own record
Start an Inve Case for PRIORITY
Free account: one company. Everything above stays public.
Write why you follow PRIORITY and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Learn to analyse PRIORITY
Guides on how to read this kind of business and the numbers that matter.